Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
131M
-
Shares change
-
+5.64M
-
Total reported value, excl. options
-
$1.7B
-
Value change
-
+$65.4M
-
Put/Call ratio
-
2.95
-
Number of buys
-
62
-
Number of sells
-
-50
-
Price
-
$12.96
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q3 2014
168 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q3 2014.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 131M shares
of 162M outstanding shares and own 80.89% of the company stock.
Largest 10 shareholders include FMR LLC (19.8M shares), WELLINGTON MANAGEMENT CO LLP (16.9M shares), JANUS CAPITAL MANAGEMENT LLC (13.1M shares), ORBIMED ADVISORS LLC (12M shares), MORGAN STANLEY (8.05M shares), VANGUARD GROUP INC (7.32M shares), BVF INC/IL (5.6M shares), DEUTSCHE BANK AG\ (5.36M shares), STATE OF WISCONSIN INVESTMENT BOARD (4.87M shares), and BlackRock Fund Advisors (4.78M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.